Lung cancer is the leading form of cancer death worldwide in both men and women, making up almost 25% of all cancer deaths. However, the number continues to drop due in part to advances in early detection and treatment.  

Lung nodules are particularly difficult to access because they are highly mobile and the needle path can be obstructed by anatomical obstacles. The XACT ACE Robotic System enables the user to plan and follow deep and complex trajectories, while the proprietary S Drive technology compensates for respiratory and target movement to ensure the accurate placement of instruments.

Liver cancer is one of the most common cancers worldwide. The incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.  

The liver is mobile and adjacent to several vital organs and blood vessels.  Safely accessing lesions, especially those in the dome, can be problematic.  Given the location, there are many critical structures in the path of the organ.

The XACT ACE Robotic System can accurately reach lesions with long and steep trajectories, while the proprietary S Drive technology follows the user’s ongoing adjustments to the trajectory due to movement during the procedure. 

Kidney cancer is among the 10 most common cancers in both men and women, but it is nearly twice as common in men.  

Renal lesions can be difficult to access with manual techniques due to tissue density. The XACT ACE Robotic System utilizes mechanical drivers with constant insertion speed to reach targets consistently and accurately with a single insertion.

Lymph nodes can be small, surrounded by vital organs or vascular structures, and difficult to access. 

This results in the need for uncommon insertion points during the procedure to avoid transgressing healthy organs or tissues and reach the target location. 

With direct patient mounting, the XACT ACE Robotic System provides unlimited options for instrument insertion points to achieve specific and safe trajectories with unparalleled accuracy. 

While Omentum Cancer is extremely rare, the mortality rate is very high.

Lesions of the omentum are often long and narrow, making it challenging to find an appropriate insertion point that ensures the instrument remains tangential to the lesion.

With direct patient mounting, the XACT ACE Robotic System provides optimal angulation that allows the advancement of instruments to reach the diseased tissue and spare non target anatomy

Adrenal cancer is extremely rare, but when the tumor is found at the early stage and can be removed surgically, the five-year survival rate is 50-60 percent.

Located near the kidney and diaphragm, the adrenal gland is a small and highly mobile structure. The XACT ACE Robotic System’s proprietary S-Drive^™ technology leverages its ability to chart non-linear trajectories to successfully navigate through intercostal spaces to reach targets in the adrenal gland.

While lesions on the spleen are rare, they can be an extremely challenging location to access when one does occur.

This is due to the bowel and vascular anatomies that surround the location. In particular, the bowel is extremely unpredictable, with nearly constant movement throughout the procedure.

The XACT ACE Robotic System enables the user to make real-time adjustments to the trajectory throughout the procedure, while the proprietary S Drive technology compensates for movement to ensure unparalleled accuracy when placing the instruments.